Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor

INTRODUCTION: Pre‐eclampsia affects 2%–8% of pregnancies and is one of the leading causes of maternal and perinatal morbidity and mortality. First‐trimester screening using an algorithm that combines maternal characteristics, mean arterial blood pressure, uterine artery pulsatility index and biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia‐Manau, Pablo, Bonacina, Erika, Serrano, Berta, Caamiña, Sara, Ricart, Marta, Lopez‐Quesada, Eva, Vives, Àngels, Lopez, Monica, Pintado, Elena, Maroto, Anna, Catalan, Sara, Dalmau, Marta, Del Barco, Ester, Hernandez, Alina, Miserachs, Marta, San Jose, Marta, Armengol‐Alsina, Mireia, Carreras, Elena, Mendoza, Manel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Pregnancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619612/
https://www.ncbi.nlm.nih.gov/pubmed/37814344
http://dx.doi.org/10.1111/aogs.14687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619612/
https://www.ncbi.nlm.nih.gov/pubmed/37814344
http://dx.doi.org/10.1111/aogs.14687

Ejemplares similares